Seattle Genetics | SGEN - Operating Profit

Name: Seattle Genetics | SGEN - Operating Profit
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Seattle,Genetics,SGEN,Operating,Profit,stock,equity,live,intraday,earnings,share,price,historical data,chart,calendar,dividend,yield,news

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

Features Questions? Contact us Already a Member? Login

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us

Please Paste this Code in your Website

width

height

Preview

Seattle Genetics

Seattle Genetics reported $-184513000 in Operating Profit for its fiscal quarter ending in March of 2023.

	Operating Profit		Date
AbbVie ABBV:US	USD 2.77B	2.73B	Mar/2023
Acadia Pharmaceuticals ACAD:US	USD -53584000	7.52M	Mar/2023
Agios Pharmaceuticals AGIO:US	USD -90613000	119.29M	Mar/2023
Amgen AMGN:US	USD 2.03B	196M	Mar/2023
Astellas Pharma 4503:JP	JPY -48250000000	109.64B	Mar/2023
Bayer BAYN:GR	EUR 2.97B	1.54B	Mar/2023
Biogen BIIB:US	USD 507.7M	192.2M	Mar/2023
BioMarin Pharmaceutical BMRN:US	USD 59.35M	83.85M	Mar/2023
Bluebird Bio BLUE:US	USD 8.44M	17M	Mar/2023
Bristol-Myers Squibb BMY:US	USD 3.1B	1.15B	Mar/2023
Celldex Therapeutics CLDX:US	USD -32471000	4.59M	Mar/2023
Daiichi Sankyo 4568:JP	JPY -6551000000	38.1B	Mar/2023
Eisai 4523:JP	JPY 26.22B	17.65B	Mar/2023
Eli Lilly LLY:US	USD 1.49B	342.4M	Mar/2023
Esperion Therapeutics ESPR:US	USD -48605000	6.09M	Mar/2023
Exelixis EXEL:US	USD 28.83M	76.91M	Mar/2023
Genmab GEN:DC	DKK 437M	2.23B	Mar/2023
Gilead Sciences GILD:US	USD 1.7B	562M	Mar/2023
GlaxoSmithKline GSK:LN	GBP 2.08B	215M	Mar/2023
Glaxosmithkline GSK:US	GBP 2.08B	215M	Mar/2023
Immunogen IMGN:US	USD -42393000	17.17M	Mar/2023
Incyte Corp INCY:US	USD 24.77M	45.32M	Mar/2023
Insmed INSM:US	USD -148158000	3.32M	Mar/2023
Karyopharm Therapeutics KPTI:US	USD -30899000	2.97M	Mar/2023
MacroGenics MGNX:US	USD -38426000	50.41M	Mar/2023
Merck & Co MRK:US	USD 3.72B	286M	Mar/2023
Mirati Therapeutics MRTX:US	USD -193823000	17.9M	Mar/2023
Moderna Inc MRNA:US	USD -366000000	1.95B	Mar/2023
Nektar Therapeutics NKTR:US	USD -134710000	82.24M	Mar/2023
Novartis NOVN:VX	USD 2.86B	907M	Mar/2023
Pfizer PFE:US	USD 6.79B	1.62B	Mar/2023
Puma Biotechnology PBYI:US	USD 4.36M	6.71M	Mar/2023
Regeneron Pharmaceuticals REGN:US	USD 946.7M	200.1M	Mar/2023
Sarepta Therapeutics SRPT:US	USD -525417000	416.01M	Mar/2023
Seattle Genetics SGEN:US	USD -184513000	30.51M	Mar/2023
Spectrum Pharmaceuticals SPPI:US	USD -4870000	6.78M	Mar/2023
Takeda 4502:JP	JPY 88.56B	58.43B	Mar/2023
Teva Pharmaceutical Industries Ltd TEVA:IT	USD 2M	857M	Mar/2023
Vertex Pharmaceuticals VRTX:US	USD 779M	254.5M	Mar/2023
Xencor XNCR:US	USD -59365000	16.67M	Mar/2023